BRITTANI HUFFHINES: Open Payments
NPI 1831549013 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,330 in 125 payments from 28 companies in 2025. Trend: 2023 $431 · 2024 $2,123 · 2025 $2,330
Food & beverage: $2,330
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $285 |
| ABBVIE INC. | 16 | $284 |
| GlaxoSmithKline, LLC. | 21 | $233 |
| Novo Nordisk Inc | 12 | $191 |
| Otsuka America Pharmaceutical, Inc. | 8 | $191 |
| Radius Health, Inc. | 5 | $134 |
| Lundbeck LLC | 4 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| Sumitomo Pharma America, Inc. | 4 | $88 |
Products named: REXULTI, MOUNJARO, CREON, Wegovy, Tymlos, TRELEGY ELLIPTA, VRAYLAR, Kerendia.
Industry payments across TX — which companies pay providers there.
